SCHEMBL21451721

SCHEMBL21451721

Clc1ccc2cc3c(cc2c1)[nH]c1cc(Cl)ccc13

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.50
▸ TP53 P04637 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CYP2A6 P11509 1/20 0.43
▸ LMNA P02545 3/20 0.43
▸ F11 P03951 1/20 0.43
▸ HPGD P15428 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CMA1 P23946 1/20 0.42
▸ AHR P35869 1/20 0.42
▸ CHUK O15111 1/20 0.42
▸ MAT2A P31153 2/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ PTGS2 P35354 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ABCC4 O15439 1/20 0.41
▸ C5 P01031 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717474 0.89 CHUK (0.50) PARP1SMN1; SMN2CYP2A6LMNAF11
SCHEMBL21448261 0.89 ALDH1A1 (0.50) PARP1TP53SMN1; SMN2CYP2A6LMNA
SCHEMBL30180882 0.89 ALDH1A1 (0.50) PARP1TP53SMN1; SMN2CYP2A6LMNA
SCHEMBL21448386 0.87 AHR (0.57) SMN1; SMN2CYP2A6LMNAHPGDALDH1A1
SCHEMBL30180942 0.87 AHR (0.57) SMN1; SMN2CYP2A6LMNAHPGDALDH1A1
SCHEMBL30180806 0.87 AHR (0.57) SMN1; SMN2CYP2A6LMNAHPGDALDH1A1
SCHEMBL21448183 0.87 AHR (0.57) SMN1; SMN2CYP2A6LMNAHPGDALDH1A1
SCHEMBL2141394 0.83 PARP1 (0.61) PARP1TP53SMN1; SMN2LMNAHPGD
SCHEMBL6009587 0.83 PARP1 (0.65) PARP1TP53SMN1; SMN2LMNAHPGD
SCHEMBL31167250 0.83 PARP1 (0.65) PARP1TP53SMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12495717-B2 Amine compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2025-12-09 — — US disclosed
US-20210057650-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2021-02-25 — — US disclosed
US-20210057650-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2021-02-25 — — US disclosed
WO-2019194617-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME 주식회사 엘지화학 2019-10-10 — — WO disclosed
WO-2019194617-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME 주식회사 엘지화학 2019-10-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12495717-B2 Amine compound and organic light emitting diode comprising same DRD1, RNF10, DRD2 PARP1 3184/4885TP53 4217/4885SMN1; SMN2 1631/4885
US-20210057650-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME DRD1, RNF10, DRD2 PARP1 3184/4885TP53 4217/4885SMN1; SMN2 1631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback